$70M Risperdal Verdict
On July 1, 2016, a Philadelphia jury returned its verdict in the amount of $70 million against Janssen Pharmaceuticals, Inc., which manufactures the antipsychotic medication Risperdal. The Philadelphia verdict is the largest verdict so far in the mass tort litigation involving Risperdal claims that [...]